Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2013
Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse modelAyako Masaki, Takashi Ishida, Susumu Suzuki, et al.
The Journal of Infectious Diseases|August 9, 2014
Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathyJunji Yamauchi, Ariella Coler-Reilly, Tomoo Sato, et al.
Plos Pathogens|January 20, 2017
HTLV-1 Tax Induces Formation of the Active Macromolecular IKK Complex by Generating Lys63- and Met1-Linked Hybrid Polyubiquitin ChainsYuri Shibata, Fuminori Tokunaga, Eiji Goto, et al.
Cancer Science|June 28, 2012
Tax is a potential molecular target for immunotherapy of adult T-cell leukemia/lymphomaSusumu Suzuki, Ayako Masaki, Takashi Ishida, et al.
Oncogene|April 24, 2002
Involvement of IL-2/IL-2R system activation by parasite antigen in polyclonal expansion of CD4(+)25(+) HTLV-1-infected T-cells in human carriers of both HTLV-1 and S. stercoralisMasao Satoh, Hiromu Toma, Kazuyuki Sugahara, et al.
AIDS Research and Human Retroviruses|September 18, 2013
Genes related to antiviral activity, cell migration, and lysis are differentially expressed in CD4(+) T cells in human t cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patientsMariana Tomazini Pinto, Tathiane Maistro Malta, Evandra Strazza Rodrigues, et al.
Blood|January 15, 2010
Aberrant expression of the transcription factor Twist in adult T-cell leukemiaHiroe Tanji, Chie Ishikawa, Shigeki Sawada, et al.
Blood Advances|March 21, 2020
Proteomic profiling of HTLV-1 carriers and ATL patients reveals sTNFR2 as a novel diagnostic biomarker for acute ATLCarmina Louise Hugo Guerrero, Yoshiko Yamashita, Megumi Miyara, et al.
The Journal of Biological Chemistry|December 9, 2008
Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastasesZhiqiang Xu, Michelle A Hurchla, Hongju Deng, et al.
Molecular Cancer|March 7, 2015
OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapyIchiyo Shibahara, Ryuta Saito, Rong Zhang, et al.
Pageof 24